Alto Mayo Peru Cacao (Theobroma cacao)

Alto Mayo Peru Cacao (Theobroma cacao) is a distinct cacao variety containing bioactive flavonoids and polyphenols that demonstrate anti-inflammatory properties. The ethanolic extract reduces inflammatory markers IL-6 and sVCAM-1 in endothelial cells at concentrations of 25-100 ppm.

Origin & History

Alto Mayo Peru Cacao is a cultivar variant of Theobroma cacao L., a tropical evergreen tree native to the Amazon basin, specifically cultivated in Peru's Alto Mayo region. The bioactive compounds are extracted from fermented and dried beans using methods such as ethanolic, chloroform, or aqueous processing to yield polyphenols, flavonoids, and alkaloids.

Historical & Cultural Context

Theobroma cacao L., known as the 'food of the gods,' has been integral to human culture and diet for thousands of years and used worldwide in traditional medicine against various ailments. No specific traditional uses for the Alto Mayo Peru cultivar were identified in the research.

Health Benefits

• May reduce inflammatory markers in endothelial cells (in vitro evidence showed 25-100 ppm ethanolic extract reduced IL-6 and sVCAM-1 levels in preeclamptic plasma-exposed cells)
• Potential anticancer properties through inhibition of cell proliferation and induction of apoptosis (preclinical studies only)
• May attenuate endothelial dysfunction associated with preeclampsia (in vitro evidence, PMID: 26955771)
• Possible cardioprotective effects through platelet function modulation (pilot human studies PMID: 36100318, 12791625, outcomes not detailed)
• Antioxidant activity via polyphenols targeting oxidative stress pathways (in vitro/computational evidence only)

How It Works

Alto Mayo Peru Cacao's flavonoids and polyphenols modulate inflammatory pathways by inhibiting pro-inflammatory cytokine IL-6 production and reducing soluble vascular cell adhesion molecule-1 (sVCAM-1) expression in endothelial cells. The bioactive compounds appear to interfere with NF-κB signaling pathways that regulate inflammatory responses. Additionally, the extract demonstrates antiproliferative effects through induction of apoptotic pathways in cancer cell lines.

Scientific Research

Clinical evidence for Alto Mayo Peru Cacao is extremely limited, with no completed human RCTs or meta-analyses identified. The ECLAIR pilot study (PMID: 36100318) examined cocoa's effect on platelet function in coronary artery disease patients, and another 28-day supplementation study (PMID: 12791625) tested dietary cocoa flavanols on platelet modulation, though specific outcomes were not detailed in abstracts.

Clinical Summary

Current evidence is limited to in vitro studies examining Alto Mayo Peru Cacao's effects on endothelial cells exposed to preeclamptic plasma. The ethanolic extract at 25-100 ppm concentrations significantly reduced inflammatory markers IL-6 and sVCAM-1 levels. Preclinical studies suggest anticancer properties through cell proliferation inhibition and apoptosis induction, but specific mechanisms and dosages require further investigation. Human clinical trials are needed to validate these preliminary findings and establish therapeutic applications.

Nutritional Profile

Alto Mayo Peru Cacao (Theobroma cacao) raw/minimally processed beans contain approximately: Fat 40-50% dry weight (predominantly cocoa butter composed of oleic acid ~35%, stearic acid ~34%, palmitic acid ~26%); Protein 10-15% dry weight (rich in glutamic acid, aspartic acid, and arginine); Carbohydrates 20-30% dry weight including dietary fiber ~15-20% (insoluble lignin, cellulose; soluble pectin fractions); Net digestible carbohydrates ~5-10%. Bioactive compounds: Methylxanthines including theobromine 1.5-3.7% dry weight and caffeine 0.1-0.7% dry weight; Polyphenols 3-10% dry weight in raw beans (decreasing significantly with fermentation and roasting), primarily flavan-3-ols including (-)-epicatechin (~35 mg/g in unfermented beans), (+)-catechin, and procyanidin oligomers (B1, B2, C1); Flavonols including quercetin and its glycosides. Minerals: Magnesium ~270-500 mg/100g dry weight; Iron ~3.6-13.9 mg/100g; Zinc ~4-9 mg/100g; Copper ~3.8 mg/100g; Manganese ~1.7 mg/100g; Phosphorus ~500-700 mg/100g; Potassium ~1500 mg/100g. Vitamins: modest B-complex including thiamine (B1) ~0.1 mg/100g, riboflavin (B2) ~0.2 mg/100g, niacin (B3) ~1.7 mg/100g; Vitamin E (tocopherols) ~0.5 mg/100g. Alto Mayo origin (San Martin region, Peru, ~800-1800m altitude) is associated with fine-flavor Trinitario or Criollo-hybrid genotypes, which tend to yield higher flavan-3-ol concentrations and more complex aromatic precursors compared to Forastero varieties. Bioavailability notes: Epicatechin bioavailability is moderate (~20-30% absorbed in small intestine); procyanidins show limited absorption and are largely metabolized by colonic microbiota into smaller phenolic acids (3,4-dihydroxyphenylacetic acid, hippuric acid) which may account for systemic effects; fat-soluble compounds bioavailability enhanced by co-consumption with cocoa butter; phytic acid content (~1.8% dry weight) may reduce mineral absorption of iron and zinc by 30-50%; theobromine is well-absorbed (~85-100%) with plasma half-life of 6-10 hours.

Preparation & Dosage

No clinically studied dosage ranges for Alto Mayo Peru Cacao or standardized T. cacao extracts have been established in human trials. In vitro studies used ethanolic extracts at 25-100 ppm. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, Resveratrol, Quercetin, Vitamin C, Curcumin

Safety & Interactions

Safety data for Alto Mayo Peru Cacao extract is limited due to lack of human clinical trials. As a cacao derivative, it may interact with caffeine-sensitive medications and could potentiate effects of stimulants. Individuals with chocolate allergies should exercise caution with cacao-based supplements. Pregnant and breastfeeding women should consult healthcare providers before use, especially given the preliminary research on preeclampsia-related pathways.